The Europe Drug Testing Market would witness market growth of 4.3% CAGR during the forecast period (2021-2027).
Increasing supportive regulations and mandates are expected to boost the growth of the European drug testing market in the upcoming years. For example, workplace drug testing is legal in the UK; however, under some conditions. Employers require employee consent to test for drugs either before or during employment. Along with this, workplace drug testing is legal in France also; however only during employment: tests cannot be performed prior to a contract is signed. Once joined a company, employees can take the test as per the internal norms and regulations of the employer, provided the impact of drugs is expected to become a threat. These supportive policies of drug testing in various countries of this region would fuel the demand & growth of the regional drug testing market during the forecast period.
The right to privacy and prohibition of drug and alcohol testing in various countries are expected to be a leading factor that is slowing down the growth & demand of drug testing in the next few years. In various European nations, like Finland and Belgium, there are strict privacy rights that cannot be neglected while testing for substance abuse. In the Netherlands, pre-employment substance abuse testing is illegal. Several European nations issue penalties for improper testing, with criminal fines. This was a breach of the worker’s privacy. Therefore, these strict privacy rights are expected to hinder the testing process at workplaces, thereby limiting the growth of the market.
The German market dominated the Europe Drug Testing Oral Fluid Samples Market by Country 2020, thereby, achieving a market value of $202.4 million by 2027. The UK market is showcasing a CAGR of 3.3% during (2021 - 2027). Additionally, The France market is poised to grow at a CAGR of 4.8% during (2021 - 2027).
Based on Drug Type, the market is segmented into Cannabis/Marijuana, Opioids, Cocaine, Alcohol, Amphetamine & Methamphetamine, LSD and Others. Based on Sample Type, the market is segmented into Urine Samples, Oral Fluid Samples, Hair Samples and Other Samples. Based on Product Type, the market is segmented into Consumables, Instruments, Rapid Testing Devices and Services. Based on End User, the market is segmented into Drug Testing Laboratories, Workplaces, Hospitals and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Global Drug Testing Market Size will Hit $11.7 Billion by 2027, at a CAGR of 5.1%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Quest Diagnostics, Incorporated, Abbott Laboratories, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific, Inc., Siemens AG (Siemens Healthineers), Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Dragerwerk AG & Co. KGaA, Quidel Corporation, and Omega Laboratories, Inc.
By Drug Type
By Sample Type
By Product Type
By End User
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
